JPH0420298A - Vice and method for pre-treating bone marrow - Google Patents
Vice and method for pre-treating bone marrowInfo
- Publication number
- JPH0420298A JPH0420298A JP2119859A JP11985990A JPH0420298A JP H0420298 A JPH0420298 A JP H0420298A JP 2119859 A JP2119859 A JP 2119859A JP 11985990 A JP11985990 A JP 11985990A JP H0420298 A JPH0420298 A JP H0420298A
- Authority
- JP
- Japan
- Prior art keywords
- bone marrow
- cells
- solution
- specimen
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001185 bone marrow Anatomy 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 16
- 210000004027 cell Anatomy 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 claims abstract description 22
- 210000001519 tissue Anatomy 0.000 claims abstract description 21
- 210000000601 blood cell Anatomy 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 12
- 239000007853 buffer solution Substances 0.000 claims abstract description 10
- 108091005804 Peptidases Proteins 0.000 claims abstract description 8
- 238000005070 sampling Methods 0.000 claims abstract description 4
- 102000004142 Trypsin Human genes 0.000 claims abstract description 3
- 108090000631 Trypsin Proteins 0.000 claims abstract description 3
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 3
- 239000012588 trypsin Substances 0.000 claims abstract description 3
- 239000012530 fluid Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 12
- 102000035195 Peptidases Human genes 0.000 claims description 6
- 238000007781 pre-processing Methods 0.000 claims description 5
- 239000004365 Protease Substances 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000012567 pattern recognition method Methods 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000699662 Cricetomys gambianus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229910021205 NaH2PO2 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009583 bone marrow aspiration Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- OCXHOPGYRWJRDH-UHFFFAOYSA-N helium;hydrochloride Chemical compound [He].Cl OCXHOPGYRWJRDH-UHFFFAOYSA-N 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229910000032 lithium hydrogen carbonate Inorganic materials 0.000 description 1
- HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N oxalic acid Substances OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業−1−の利用分野〕
本発明は、骨髄像標本作製のため前処理段階で骨髄組織
中の細胞(血球)を分離し得る処理方法及びその処理を
用いた装置に関する。[Detailed Description of the Invention] [Field of Application in Industry-1-] The present invention provides a processing method capable of separating cells (blood cells) in bone marrow tissue in a pretreatment stage for preparing a bone marrow image specimen, and a method using the processing. Regarding equipment.
骨髄像検査とは、〃;(因不明の貧血や白血病なとの疾
患の病態を把握するために行う検査である。A bone marrow imaging test is a test performed to understand the pathology of diseases such as unexplained anemia and leukemia.
後腸骨及び胸骨に穿刺し、骨髄液を0.5〜1 、 O
mρ吸引し、塗抹標本を作製する。動物(例:ラッ1〜
)の場合は、大腿骨の先端を切断し、血清入りのシリン
ジを当てて、骨中の骨fli $II lfaを洗い出
す。Puncture the posterior ilium and sternum and collect bone marrow fluid at 0.5 to 1 O.
Aspirate mρ and prepare a smear. Animals (e.g. Rat 1~
), cut off the tip of the femur and apply a syringe containing serum to wash out the bone fli $II lfa in the bone.
採取した組織液は、用手法あるいは自動塗抹法て塗抹す
る。ヒトの場合はとんど用手法で行われ、ウェッジ法と
カバースリップ法の2種類がある。The collected tissue fluid is smeared manually or using an automated smear method. In the case of humans, it is usually performed using two methods: the wedge method and the coverslip method.
用手法の場合、抗凝固剤は使わず、凝固する前に、すば
やく塗抹しなければならない。組織中の脂肪がしやまし
て、ス11−スな塗抹は大変何がしい。In the manual method, no anticoagulant is used and it must be smeared quickly before it clots. The fat in the tissue has faded and a smooth smear is very dangerous.
サイI−センI〜リフユージという自動分類装置は主に
動物実験で使われている。体液の細胞診のための標本作
製に本来用いられていたものである。An automatic classification device called Sai-I-Sen-I~Rejuge is mainly used in animal experiments. It was originally used to prepare specimens for cytodiagnosis of body fluids.
抗凝固剤入りの組織液を等張緩衝液等で遠心洗浄してか
ら遠沈室に入れ、その出[コの部分にスライドカラスを
装着する。7 cn径の穴のあいた細長いろ紙を遠沈室
どスタイ1−カラスの間にはさみ、ろ紙にあれられだ穴
の部分て両者が接するようになっている。遠沈により、
液体はろ紙に吸着されるため、スライI・ガラス]−に
は、細胞が乾いた状態で集められ、小円形の塗抹面が作
製される。The tissue fluid containing an anticoagulant is centrifugally washed with an isotonic buffer, etc., then placed in a centrifugation chamber, and a slide glass is attached to the outlet. A long and thin filter paper with a hole of 7 cn diameter is sandwiched between the centrifuge chamber and the crow, so that the holes in the filter paper make contact between the two. By centrifugation,
Since the liquid is adsorbed by the filter paper, the cells are collected in a dry state on the Sly I glass, creating a small circular smear surface.
1−記の遠心洗浄は、骨髄組織液の余分な脂肪や相識を
取り除くために行オ)れる。抗凝固剤入りの組織液をス
ピッツ管に入れ、等張緩衝液または血清を適量加えて、
混合してから遠心機にセットする。1,500−2,5
00rpmで3〜5分遠心し、取り出す。」−清をピペ
ツ1へて吸い」二げ棄てる。これを2〜3回繰り返す。The centrifugal washing described in 1- is performed in order to remove excess fat and fat from the bone marrow tissue fluid. Put tissue fluid containing anticoagulant into a Spitz tube, add an appropriate amount of isotonic buffer or serum,
Mix and place in the centrifuge. 1,500-2,5
Centrifuge at 00 rpm for 3-5 minutes and remove. ” - Pipette 1 and suck it up, then throw it away. Repeat this 2 to 3 times.
作製した塗抹標本は染色を施し、顕微鏡下で細胞(血球
)を500〜1000個分類する。(末:(
梢血標木の場合は]、 O0〜200個)熟練した技師
でも一検体検査するのに20〜30分かかり、非常に疲
れる作業である。The prepared smear is stained, and 500 to 1000 cells (blood cells) are classified under a microscope. (End: (In the case of tree branches) O0 to 200 pieces) Even an experienced technician takes 20 to 30 minutes to test one sample, which is extremely tiring work.
I−記従来技術の用手法は、目視分類しかできない標本
で、血球が5〜10個程度程度たまりになっている。ウ
ェッジ法の引き終りには血球の壊れも多い。The method used in the prior art described in I-1 is for specimens that can only be visually classified, with a collection of about 5 to 10 blood cells. Blood cells often break down at the end of the wedge method.
自動塗抹θ((サイ1へセン1ヘリフユージ)において
は、遠心洗浄に時間と手間がかかり、細胞(血球)も壊
れやすく、大形の未熟な細胞(血球)がくっつきやすい
傾向しこある。また、塗抹された小P]形の大きさは直
径約7 nnnて位置もずれるため、自動分類装置での
分類には適さない。In automatic smearing θ ((Sai 1 Hesen 1 Herifuge)), centrifugal washing takes time and effort, cells (blood cells) are easily destroyed, and large immature cells (blood cells) tend to stick together. , smeared small P] shape is approximately 7 mm in diameter and the position is shifted, so it is not suitable for classification by an automatic classification device.
末梢血標本は、パターン認識法による血液像自動分類装
置において、孤)′/、シた細胞(血球)の等徴パラメ
ータにより分類を行っている3、添付した資料によると
、細胞(血球)が孤立していなくても、2〜73個であ
れば、処理能力は下がるが、分類が可能であることがわ
かっている。Peripheral blood specimens are classified by an automatic blood image classification device using a pattern recognition method based on the isomorphic parameters of the cells (blood cells).3 According to the attached document, the cells (blood cells) are It is known that even if they are not isolated, if there are 2 to 73, classification is possible, although the processing capacity will be reduced.
本発明は、タンパク質分解酵素処理により、骨髄組織液
中の細胞(血球)を2〜3個程程度分離することを目的
とする。The purpose of the present invention is to separate about 2 to 3 cells (blood cells) in bone marrow tissue fluid by treatment with a proteolytic enzyme.
本発明の他の目的は、遠心機にサンプリング。Another object of the invention is sampling in a centrifuge.
洗浄、撹拌機構を伺加することにより、自動的に遠心洗
浄、酵素処理を同一容器内で行い、しかも特定細胞の比
率に変化がなく、壊れの少ない細胞′1¥遊液を作製す
る前処理装置を提供することにある。By adding a washing and stirring mechanism, centrifugal washing and enzyme treatment are automatically carried out in the same container, and the ratio of specific cells does not change, and the pre-treatment creates a cell suspension with less breakage. The goal is to provide equipment.
L記口的些達成するために、タンパク質分解酵素を採用
し、骨髄組織液と酵素の等張緩衝溶液を定温度に加温し
た容器内で作用させ、血球を壊さずに]−〜3個程度に
分離するものである。In order to achieve this goal, a proteolytic enzyme was used, and bone marrow tissue fluid and an isotonic buffer solution of the enzyme were allowed to react in a container heated to a constant temperature, without destroying the blood cells. It is separated into two parts.
さらに、組織液を採取した容器を遠心機へ設置した後、
自動的に前処理を行うために、遠心機にザンプリンタ機
構(試薬分注と上清除去)と洗浄機構(ノスル洗浄)、
及び撹拌機構を付加したものである。Furthermore, after placing the container containing the tissue fluid in a centrifuge,
In order to automatically perform pretreatment, the centrifuge is equipped with a sampliner mechanism (reagent dispensing and supernatant removal) and a washing mechanism (nostle washing).
and a stirring mechanism added.
〔イ1用〕
本発明で使用するタンパク質分解酵素は、消炎効果のあ
る酵素で、そのうち、トリプシンは壊死組織+ l1g
などを融解する働きがある。他にコラゲナーセ、ス1−
1ノブI−キナーゼ、α−キモ1−リプシン、プロメラ
イン、パパインなどがあり、同様の働きを有する。ある
濃度の酵素をそれぞれの至適p I−1に調製した等張
緩衝液と混合し、30〜37℃に加温して容器で、骨髄
組織液と作用させると酵素が組織液中の余分な脂肪組織
を融解し、血球1漠にも作用して、血球を分離する。[For A1] The proteolytic enzyme used in the present invention is an enzyme that has an anti-inflammatory effect, and trypsin is used for necrotic tissue + l1g.
It has the function of melting things such as In addition, collagenase, S1-
1-knob I-kinase, α-chymo-1-lipsin, promelain, papain, etc., have similar functions. When a certain concentration of enzyme is mixed with an isotonic buffer solution adjusted to its optimum p I-1, heated to 30-37°C, and allowed to interact with bone marrow tissue fluid in a container, the enzyme removes excess fat in the tissue fluid. It melts the tissue and acts on the blood cells to separate them.
〔実施例〕 骨髄組織液をヒ1〜あるいは動物より採取する。〔Example〕 Bone marrow tissue fluid is collected from humans or animals.
ヒ1−の場合、医師が骨髄穿刺し、0.5〜1−1−1
Oシリンジで吸引する。小動物の場合、剖検時、大腿骨
を切断し、血清人りシリンジにて、押し出す。In the case of H1-, the doctor performs bone marrow aspiration and
Aspirate with an O syringe. In the case of small animals, at the time of autopsy, cut the femur and extrude it with a serum syringe.
ます、酵素処理液と等張緩衝液を以下の通りに調製する
。First, prepare the enzyme treatment solution and isotonic buffer as follows.
■ 丁) 丁3 S緩衝液 ・ 20 丁n 【也■
l−リプシン・50mQ
■は使用時にp Hを7〜8に調整し、■を20mQと
■を50 m Q混合して作製する。■ D) D3 S buffer solution ・ 20 D [也■
l-Lipsin 50 mQ (2) is prepared by adjusting the pH to 7 to 8 before use, and mixing 20 mQ (2) and 50 mQ (2).
・塩化す1ヘリウム(NaCQ)
4、Q g / 500mQ
・塩化カリウム(KCQ、)
0.2 g1500mQ
・塩化カルシウム(Ca CQ 2)
0.28g1500mQ
・リン酸水素ナトリウム(NaH2PO2・2H20)
39.0mg1500mQ
・リン酸水素ナトリウム(N a zHP O4・12
H2O)76.0g/ 500 m Q
・炭酸水素す1〜リウム(NaI−(CO2)175m
g1500mff
第1図に装置の構成、第2図に前処理装置の処理工程を
示す。酵素処理液1は試薬容器3に約20 m Q入れ
て設置r1する。痔す1(緩衝液は試薬容器2に約50
On+ Q入れ設置する。洗浄水はイオン交換水また
は蒸留水を洗浄水容器1:3に約500r丁)Q人才し
て才9く。・Sulfur 1 helium chloride (NaCQ) 4,Q g / 500mQ ・Potassium chloride (KCQ, ) 0.2 g1500mQ ・Calcium chloride (Ca CQ 2) 0.28g1500mQ ・Sodium hydrogen phosphate (NaH2PO2・2H20)
39.0mg1500mQ ・Sodium hydrogen phosphate (N a zHP O4・12
H2O) 76.0g/500 m Q ・Lithium hydrogen carbonate (NaI-(CO2) 175m
g1500mff Fig. 1 shows the configuration of the device, and Fig. 2 shows the processing steps of the pretreatment device. Enzyme treatment solution 1 is placed in reagent container 3 by approximately 20 mQ and installed r1. Hemorrhoids 1 (buffer solution is approximately 50% in reagent container 2)
On+ Install Q insert. For cleaning water, use ion-exchanged water or distilled water at a ratio of 1:3 to approximately 500 liters).
ヒ1へや動物の種類によって、遠心の最適回転時間、撹
拌最適時間が異なるため、あらかじめ、操作キーボー1
−′4より液晶パネル5て設定する。The optimal rotation time for centrifugation and the optimal stirring time differ depending on the type of animal and the type of animal.
- Set the LCD panel 5 from '4.
採取した骨髄組織液を抗凝固剤(EDTA)が乾固しで
ある容器6に入れ、遠心機構のホールタフに置き、固定
する。操作キーボーI−4の5TARTキーを押すと、
等張緩衝液を試薬容器]2からデイスペンサ8て吸引し
、ノスル9より容器6に吐出する。撹拌棒↓」−により
5〜土O秒間撹拌する(500−1.OOOrpm)
。その後、遠心機構のフタIJの71・12を閉め、1
,500±300rpnlで3〜7分遠心する1、#了
後マl−12が開き、ノスル9て容器6内部の上清を吸
引し、装置外部の排液タンク]3に排出する。等張緩衝
液の公理から上清を排出するまでを設定回数繰り返し洗
浄する。The collected bone marrow tissue fluid is placed in a container 6 in which an anticoagulant (EDTA) has been dried and placed in a hole tough of a centrifugal mechanism to be fixed. When you press the 5TART key on the operation keyboard I-4,
The isotonic buffer solution is aspirated from the reagent container 2 by the dispenser 8 and discharged from the nostle 9 into the container 6. Stir for 5 to 0 seconds using a stirring bar (500-1.OOOrpm)
. After that, close the lids 71 and 12 of the centrifugal mechanism lid IJ, and
After centrifuging for 3 to 7 minutes at 500±300 rpm, 1, #1 is opened, the supernatant inside the container 6 is aspirated through the nostle 9, and discharged into the drainage tank] 3 outside the apparatus. Repeat washing a set number of times from the axiom of isotonic buffer to draining the supernatant.
その後、酵素処理液を試薬容器21より吸引し、ノスル
9より容器6に吐出し、撹拌棒10で5〜10秒間撹拌
し、71−12を閉し5〜10分放置する。処理終了後
、]、 、 500±30Q rpmで3〜7分遠心す
る。それからマド]2を開け、容器6内の1−清を吸引
する。さらに試薬容器2から等張緩衝液をティスペンサ
Δ8で吸引し、容器6に吐出し、撹拌棒10て5・〜1
0秒撹拌する(500−1. OOOrpm)。Thereafter, the enzyme treatment solution is sucked from the reagent container 21, discharged from the nozzle 9 into the container 6, stirred for 5 to 10 seconds with the stirring rod 10, closed 71-12, and left for 5 to 10 minutes. After finishing the treatment, centrifuge at 500±30Q rpm for 3 to 7 minutes. Then, open the container 2 and aspirate the liquid 1 in the container 6. Furthermore, the isotonic buffer solution is aspirated from the reagent container 2 with the dispenser Δ8, discharged into the container 6, and stirred with the stirring bar 10.
Stir for 0 seconds (500-1.OOOrpm).
撹拌棒]O,ノスル9は洗浄水をディスベンザ81、5
で吸引し1検体毎に洗浄槽14内で洗浄する。洗浄槽1
4内の水はl・レインをとおって装置外部の排液タンク
13に排出する。これで前処理装置での処理は完了であ
る。Stirring bar] O, nosle 9 dispenses washing water with dispenser 81, 5
suction and washing each sample in the washing tank 14. Cleaning tank 1
The water in the tank 4 is discharged to a drain tank 13 outside the device through a l-rain. The processing in the preprocessing device is now complete.
第3図に装置の遠心機構の詳細を示す。駆動モータ1−
7を断熱材18を貼ったベース19でかこめ、モータ軸
上に容器6を保持するホルダ7を固定する。高速(1,
000〜3 、00 Orpm)で回転するため、振動
しないようバネ20を設け、さらにモータからの発熱を
にかすため、風穴21を設ける。Figure 3 shows details of the centrifugal mechanism of the device. Drive motor 1-
7 is surrounded by a base 19 pasted with a heat insulating material 18, and a holder 7 for holding the container 6 is fixed on the motor shaft. High speed (1,
Since the motor rotates at a speed of 000 to 3,000 rpm, a spring 20 is provided to prevent vibration, and an air hole 21 is provided to prevent heat generation from the motor.
71〜12が閉まると、設定時間遠心するようにも制御
部16で制御する。作業中、誤って、試料がこぼれた場
合のため、受(づ皿22を伺加した。When 71 to 12 are closed, the controller 16 also controls the centrifugation for a set time. A catch tray 22 was added in case the sample accidentally spilled during work.
また、ヒータ23て容器6全体を30〜37°Cに加温
し、湿度センサ24しこより、適温に維持するように制
御する。Further, the entire container 6 is heated to 30 to 37° C. by the heater 23, and controlled to be maintained at an appropriate temperature by the humidity sensor 24.
前処理装置での処理終了後、容器6を取り出し既存の遠
心式塗抹装置′、9′を用いてスライ1〜カラスに塗抹
し、染色を施す。作製した標本は、パターン認識法によ
る血液像自動分類装置において、自動で骨髄像を分類さ
せる。After the treatment in the pretreatment device is completed, the container 6 is taken out and the slides 1 to 1 are smeared and stained using the existing centrifugal smear devices ′, 9′. The prepared specimen is automatically classified as a bone marrow image using a blood image automatic classification device using a pattern recognition method.
使用するタンパク質分解酵素は1〜リプシン以外にコラ
ゲナーセで代用できる。また、細胞公証を助けるため、
キレ−1へ剤のE l) i″A(エチレンシアミンチ
1〜う酸)を酵素液に加える方法もある。The proteolytic enzyme used can be substituted with collagenase in addition to 1-lipsin. Also, to help with cell notarization,
There is also a method of adding a chemical agent to the enzyme solution, E1) i''A (ethylene cyamine thiol-oxalic acid).
酵素の濃度は、I−リプシンで0.2〜0,5%、コラ
ゲナ・−ゼて0.02〜0.1%が適当である。ン容解
する緩衝液と酵素と1’: D i” Aの絹合せは何
種類かあり、次に例をあげる。Suitable enzyme concentrations are 0.2-0.5% for I-lipsin and 0.02-0.1% for collagenase. There are several types of silk combinations of buffer solution, enzyme, and 1':D i''A, and examples are given below.
(例A)
i)等張緩新液 20m(1
塩化す1−リウム(NclCQ)
4、 、 Oy、 / 500 rn Q塩化カリウム
(KCQ)
0.2 g / 500 m Q。(Example A) i) Isotonic buffer solution 20 m (1 1-lium chloride (NclCQ) 4, , Oy, / 500 rn Q Potassium chloride (KCQ) 0.2 g / 500 m Q.
塩化力ルシウl\(cacQz)
0.28g1500mQ
ノン酸水素す1〜リウム(N a HzP 04 ・2
1−TzO)39mg1500mM
リン酸水素す1−リウム(N a 2I(P 04・1
21−TzO)76 mg / 500 m Q
炭酸水素す1−リウム(NaHCO3)175mg/
500m Q。Lucium chloride (cacQz) 0.28g1500mQ Hydrogen non-acid 1~lium (N a HzP 04 ・2
1-TzO) 39mg1500mM 1-lium hydrogen phosphate (N a 2I (P 04・1
21-TzO) 76 mg / 500 m Q 1-lium hydrogen carbonate (NaHCO3) 175 mg /
500m Q.
く■ コラゲナーゼ・iomg(0,05%)(3)1
〜リブシンインヒビター 1mg(例B)
1) P B S 緩衝i1−11−2O(p、9参
照)(?)1へリプシン・ 50 mg
t’3)E D T A −4、6mg酵素の濃度を高
くしたり、処理時間を長くすると、分離した細胞(血球
)にも作用して、細胞膜を壊すため、濃度や時間に気を
配る必要がある1、〔発明の効果〕
本発明は、以1−説明したように構成されているので以
ドに記載されるような効果を奏する。■ Collagenase/iomg (0.05%) (3) 1
~ Ribsin inhibitor 1 mg (Example B) 1) P B S buffer i1-11-2O (see p, 9) (?) 1 Helipsin 50 mg t'3) E D T A -4, 6 mg Concentration of enzyme If the concentration is increased or the treatment time is prolonged, it will also act on the separated cells (blood cells) and destroy the cell membrane, so it is necessary to pay attention to the concentration and time. 1- Since it is configured as explained above, it produces the effects described below.
i’+ii処理[−稈を;+=作業で行うと、分注、撹
拌、さ1−′Jに遠心と−n間はかかる上、感染の危険
も大きくなる。本発明によれは、採取した骨髄組織液を
容器に入れ、装置にセラ1へするたけて、15〜20分
て細胞ン7遁/1kが作製でき、自動分類可能な標本を
提供できる。If the i'+ii treatment [-culm;+= operation is carried out, dispensing, stirring, centrifugation and -n will be required in addition to the time required for dispensing, stirring, and the process, and the risk of infection will increase. According to the present invention, by putting the collected bone marrow tissue fluid into a container and pumping it into the cellar 1 in the device, 7 cells/1k can be prepared in 15 to 20 minutes, and a specimen that can be automatically classified can be provided.
第4図に酵素処理標本と未処理標本の細胞分布図を示す
。未処理の標本では、細胞(血球)かぴったり5〜10
個接触しているが、酵素処理を行うと、細胞(1r+t
l”R) −1−3個Pu度ニ’、i: ’J、IL
存(1)、末梢血液用110液像自動分類装置で自動分
類が可能となった。処理検体数は、細胞数が末梢血の5
倍になるのであまり多くならないが、[]視分類の時間
の約3分の1になる。ただ、装置は、夜間運転すること
もでき技師の疲れを軽減させる効果がある。Figure 4 shows the cell distribution diagram of the enzyme-treated specimen and the untreated specimen. In unprocessed specimens, the cells (blood cells) are approximately 5-10
However, when enzyme treatment is performed, cells (1r+t
l"R) -1-3 Pu degree d', i: 'J, IL
(1) Automatic classification is now possible with a 110 liquid image automatic classification device for peripheral blood. The number of samples processed is 5 cells in peripheral blood.
The time is doubled, so it is not much, but it is about one-third of the time required for visual classification. However, the device can also be operated at night, which has the effect of reducing technician fatigue.
表1に、未処理標本と酵素処理標本の骨髄像分煩結果を
示す。特定の細胞(血球)の存在比率が変化することが
なく、良好な結果が得られた。Table 1 shows the results of myeloid imaging of untreated specimens and enzyme-treated specimens. Good results were obtained without any change in the abundance ratio of specific cells (blood cells).
表1 分類結果 分類個数: 1000コ/枚Table 1 Classification results Number of classification: 1000 pieces/piece
第1図は本発明の一実施例の装置の立体図、第
2図は前処理装置の処理工程図、第3図は装置の遠心機
構図、第4図は未処理と酵素処理済の標本の細胞分布図
である。
] 酵素処理液、2・試薬容器(等張緩前液)、3 ・
試薬容器(洗浄水)、6 容器、7 ホールダ、9〕・
・ノズル(サンプリング機構)、1o 撹拌棒、14・
洗浄渦、」7 モータ、」8 断熱材、23 ヒータ、
24 ・温度センサ、4(3・制御部。Fig. 1 is a three-dimensional diagram of an apparatus according to an embodiment of the present invention, Fig. 2 is a treatment process diagram of the pretreatment apparatus, Fig. 3 is a diagram of the centrifugal mechanism of the apparatus, and Fig. 4 is an untreated specimen and an enzyme-treated specimen. FIG. ] Enzyme treatment solution, 2. Reagent container (isotonic pre-relaxation solution), 3.
Reagent container (washing water), 6 container, 7 holder, 9]・
・Nozzle (sampling mechanism), 1o Stirring bar, 14・
Cleaning vortex, 7 Motor, 8 Insulation, 23 Heater,
24 ・Temperature sensor, 4 (3・Control unit.
Claims (1)
分解酵素の処理により、骨髄組織液中の細胞(血球)を
分離することを特徴とする骨髄像前処理方法。 2、請求項第1項の前処理は、トリプシン等のタンパク
質分解酵素を等張緩衝液に溶かし、その酵素の至適pH
に調整した液中において、骨髄組織中の細胞(血球)を
酵素の作用により細胞膜を破壊せず、1〜3ケずつに分
離することを特徴とする骨髄像前処理方法。 3、駆動モータの回転軸に容器を保持する板材と、一定
温度に加温したロータ部から構成されている遠心機にお
いて、サンプリング及び洗浄機構及び撹拌機構付加する
ことにより、骨髄組織液の洗浄を酵素処理を同一容器で
行うことを可能にしたことを特徴とする骨髄像前処理装
置。[Scope of Claims] 1. A bone marrow image preprocessing method, which comprises separating cells (blood cells) in bone marrow tissue fluid by treatment with a proteolytic enzyme in the preprocessing step of preparing a bone marrow image specimen. 2. The pretreatment according to claim 1 involves dissolving a proteolytic enzyme such as trypsin in an isotonic buffer solution and adjusting the optimum pH of the enzyme.
1. A method for preprocessing bone marrow images, which comprises separating cells (blood cells) in bone marrow tissues into 1 to 3 cells by the action of enzymes in a solution adjusted to 1 to 3 cells without destroying cell membranes. 3. In a centrifuge consisting of a plate that holds a container on the rotating shaft of a drive motor and a rotor heated to a constant temperature, by adding a sampling and washing mechanism and a stirring mechanism, bone marrow tissue fluid can be washed with enzymes. A bone marrow image preprocessing device characterized in that processing can be performed in the same container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2119859A JPH0420298A (en) | 1990-05-11 | 1990-05-11 | Vice and method for pre-treating bone marrow |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2119859A JPH0420298A (en) | 1990-05-11 | 1990-05-11 | Vice and method for pre-treating bone marrow |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0420298A true JPH0420298A (en) | 1992-01-23 |
Family
ID=14772042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2119859A Pending JPH0420298A (en) | 1990-05-11 | 1990-05-11 | Vice and method for pre-treating bone marrow |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0420298A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100707642B1 (en) * | 2002-08-30 | 2007-04-13 | 삼성전자주식회사 | Method for Fabricating Preform for Plastic Optical Fiber |
-
1990
- 1990-05-11 JP JP2119859A patent/JPH0420298A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100707642B1 (en) * | 2002-08-30 | 2007-04-13 | 삼성전자주식회사 | Method for Fabricating Preform for Plastic Optical Fiber |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5143627A (en) | Method and apparatus for preparing cells for examination | |
US5786207A (en) | Tissue dissociating system and method | |
JP4334601B2 (en) | Tissue fixation-dehydration-degreasing-impregnation equipment | |
JP4510898B2 (en) | Plasma concentrator | |
ES2331364T3 (en) | METHOD OF SIMPLIFIED FABRIC PROCESSING. | |
US5480484A (en) | Cytology centrifuge apparatus | |
US5240606A (en) | Apparatus for preparing cells for examination | |
US20140193852A9 (en) | Adipose tissue collection and pre-processing devices for use in liposuction procedure | |
JP2003535815A (en) | Method and apparatus for processing blood and blood components | |
JP2008519983A (en) | Improved sample preparation system for laboratory equipment | |
CN109765323A (en) | The pretreating device and method of transformer oil liquid-phase chromatographic analysis sample | |
US6830935B1 (en) | Method for mixing and processing specimen samples | |
CA2336093C (en) | Improved method for mixing and processing specimen samples | |
JPH0420298A (en) | Vice and method for pre-treating bone marrow | |
JP2002340913A (en) | Automatic analyzer | |
WO1999063324A1 (en) | A method and a device for preparing a biological specimen | |
JP2000146782A (en) | Apparatus and method for preparation of automatically fixed sample | |
CN111766128A (en) | Homogenate device for medical inspection | |
JP2547354B2 (en) | Method and apparatus for capturing sample having viscosity | |
KR100465645B1 (en) | A system for automatically extracting dna from many samples | |
US20210072123A1 (en) | Device for Processing and Infiltrating Histological and Biological Samples | |
JP3659703B2 (en) | Preparation with filter | |
CN114235524B (en) | Sputum treatment method | |
KR200259190Y1 (en) | A system for automatically extracting dna from many samples | |
CN216857676U (en) | Centrifuging tube is self-cleaning device in batches |